ProQR Therapeutics
PRQR
37 hedge funds and large institutions have $162M invested in ProQR Therapeutics in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 7 closing their positions.
88% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 8
60% more capital inflows, than outflows
Capital inflows: $13.6M | Capital outflows: $8.52M
1.29% more ownership
Funds ownership: 46.41% → 47.7% (+1.3%)
0% more funds holding
Funds holding: 37 → 37 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$3.73M |
| 2 |
Clough Capital Partners
Boston,
Massachusetts
|
+$3.62M |
| 3 |
Redmile Group
San Francisco,
California
|
+$2.41M |
| 4 |
CCM
Century Capital Management
Boston,
Massachusetts
|
+$901K |
| 5 |
Millennium Management
New York
|
+$887K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Investors US
Denver,
Colorado
|
-$2.41M |
| 2 |
EverPoint Asset Management
Stamford,
Connecticut
|
-$2.14M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.02M |
| 4 |
Ascend Capital
Orinda,
California
|
-$869K |
| 5 |
Asset Management One
Tokyo,
Japan
|
-$578K |
PRQR Hedge Fund Activity: Q3 2015 in Review
37 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q3 2015, worth a combined $162M — down 10% from $181M a quarter earlier.
Fund positioning in PRQR was balanced in Q3 2015: 7 funds opened new positions, 7 closed out, 15 added to existing stakes and 8 trimmed.
The largest buyer was Highland Capital Management (Texas), adding an estimated $3.73M. The largest seller was Janus Henderson Investors US, cutting an estimated $2.41M.
- 37 institutional investors held ProQR Therapeutics (PRQR) as of Q3 2015, unchanged from Q2 2015.
- Funds reported $162M of ProQR Therapeutics stock for Q3 2015, down 10% quarter-over-quarter.
- 7 funds opened new ProQR Therapeutics positions in Q3 2015 and 7 closed out, a net change of 0 holders.
- The largest ProQR Therapeutics buyer in Q3 2015 was Highland Capital Management (Texas), an estimated $3.73M added.
- The largest ProQR Therapeutics seller in Q3 2015 was Janus Henderson Investors US, an estimated $2.41M sold.
Based on aggregated 13F filings for Q3 2015.